(Q45201957)

10 December 2017

title

Appropriate reductions in compliance among well-controlled hypertensive patients (English)

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

16 November 2022

author name string

J. F. Steiner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1753267

16 November 2022

S. D. Fihn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1753267

16 November 2022

B. Blair

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1753267

16 November 2022

T. S. Inut

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1753267

16 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1753267

16 November 2022

publication date

1 January 1991

1 reference

full work available at URL

10 December 2017

https://api.elsevier.com/content/article/PII:089543569190097S?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

https://api.elsevier.com/content/article/PII:089543569190097S?httpAccept=text/plain

16 November 2022

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

Journal of Clinical Epidemiology

16 November 2022

published in

1 reference

10 December 2017

volume

44

1 reference

10 December 2017

issue

12

1 reference

10 December 2017

page(s)

1361-1371

1 reference

Impact of patient perceptions on compliance with treatment for hypertension

10 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

Patient compliance with antihypertensive medication

16 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

Can simple clinical measurements detect patient noncompliance?

16 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

Screening for noncompliance among patients with hypertension: is self-report the best available measure?

16 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

Compliance, treatment practices and blood pressure control: Community survey findings

16 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

Improved compliance measures: applications in an ambulatory hypertensive drug trial

16 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

Effects of withdrawing diuretic therapy on blood pressure in mild hypertension

16 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

Dietary therapy slows the return of hypertension after stopping prolonged medication

16 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

Nutritional therapy for high blood pressure. Final report of a four-year randomized controlled trial--the Hypertension Control Program

16 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

The likelihood of remaining normotensive following antihypertensive drug withdrawal.

16 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

Effects of reduction in drugs or dosage after long-term control of systemic hypertension

16 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

Clinical predictors of treatment reduction in hypertensive patients

16 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

A general method of compliance assessment using centralized pharmacy records. Description and validation

16 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

RANDOMISED CLINICAL TRIAL OF STRATEGIES FOR IMPROVING MEDICATION COMPLIANCE IN PRIMARY HYPERTENSION

16 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

Effect of prolonged treatment on haemodynamics of essential hypertension before and after autonomic block

16 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

Modifying the treatment: patient compliance, patient control and medical care

16 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

The meaning of medications: another look at compliance

16 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

Judging drugs: patients' conceptions of therapeutic efficacy in the treatment of arthritis

16 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

Correlates of attendance and compliance in the hypertension detection and follow-up program

16 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

Common-sense models of illness: the example of hypertension

16 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers

16 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

Underutilization of antihypertensive drugs and associated hospitalization

16 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0895-4356(91)90097-S

16 November 2022

Identifiers

1 reference

10 December 2017

1 reference